(0.15%) 5 139.25 points
(0.09%) 38 476 points
(0.26%) 17 892 points
(-0.01%) $83.84
(0.94%) $1.941
(0.20%) $2 352.00
(0.57%) $27.69
(2.08%) $941.25
(-0.23%) $0.933
(-0.34%) $10.99
(-0.35%) $0.798
(1.26%) $93.04
Live Chart Being Loaded With Signals
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions...
Stats | |
---|---|
Dagens volum | 562 181 |
Gjennomsnittsvolum | 4.22M |
Markedsverdi | 5.13B |
EPS | €0 ( 2024-02-28 ) |
Neste inntjeningsdato | ( €0 ) 2024-05-14 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | 94.22 |
ATR14 | €0.00600 (0.07%) |
Volum Korrelasjon
Grifols, S.A. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Grifols, S.A. Korrelasjon - Valuta/Råvare
Grifols, S.A. Økonomi
Annual | 2023 |
Omsetning: | €6.59B |
Bruttogevinst: | €2.32B (35.24 %) |
EPS: | €0.0873 |
FY | 2023 |
Omsetning: | €6.59B |
Bruttogevinst: | €2.32B (35.24 %) |
EPS: | €0.0873 |
FY | 2022 |
Omsetning: | €6.06B |
Bruttogevinst: | €2.23B (36.80 %) |
EPS: | €0.310 |
FY | 2021 |
Omsetning: | €4.93B |
Bruttogevinst: | €1.96B (39.78 %) |
EPS: | €0.267 |
Financial Reports:
No articles found.
Grifols, S.A.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.